Lifestar Pharma Llc C/O Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Lifestar Pharma Llc C/O Pharmaceutical Import Records from India — 2 Products, $1.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Lifestar Pharma Llc C/O — Pharmaceutical Importer Profile (2026) | 2 Products, $1.5M Trade | TransData Nexus

Lifestar Pharma Llc C/O

Pharmaceutical Importer · United States · Nutritional Supplements Focus · $1.5M Total Trade · DGFT Verified

Lifestar Pharma Llc C/O is a pharmaceutical importer based in United States with a total trade value of $1.5M across 2 products in 2 therapeutic categories. Based on 37 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Lifestar Pharma Llc C/O sources from 1 verified Indian supplier, with Mankind Pharma Limited accounting for 100.0% of imports.

Lifestar Pharma Llc C/O — Import Portfolio & Supplier Network

Lifestar Pharma Llc C/O import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Lifestar Pharma Llc C/O?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Mankind Pharma Limited	$367.7K	12	100.0%

Lifestar Pharma Llc C/O sources from 1 verified Indian supplier across 12 distinct formulations. The sourcing is highly concentrated — Mankind Pharma Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Lifestar Pharma Llc C/O Import?

Formulation	Value	Ships
Nitrofurantoin capsules USP(monohydrate/macrocrystals)100mg100ctbatch no. at2x012 mfg.date may-2024 exp date	$50.0K	1
Formoterol fumarate inhalation solution,20mcg/2ML 60x2ml ( qty.3765 packs) netconent of 4.74 GM of bulk drug)	$50.0K	1
Arformoterol tartrate inhalation solution 15 MCG/2 ML (0.015 MG/2 ML) 30x2ml sterile unit-dose	$50.0K	1
Tobramycin inhalation solution, USP 300MG/5 ML 56x5ml ( qty.1435 packs) net conent of 26.03664 kgs of bulk drug)	$50.0K	1
Tobramycin inhalation solution, USP 300MG/5 ML 56x5ml ( qty.1430 packs) net conent of 25.94592 kgs of bulk drug)	$50.0K	1
Atorvastatin calcium tablets 40 MG, 90sct batch no. 4kx033 mfg. date apr-2024exp date	$26.3K	1
Atorvastatin calcium tablets 40 MG, 90sct batch no. 4kx034 mfg. date apr-2024exp date	$25.9K	1
Atorvastatin calcium tablets 20 MG, 90sct batch no. 0kx024 mfg. date may-2024exp date	$18.6K	1
Atorvastatin calcium tablets 20 MG, 90sct batch no. 0kx022 mfg. date may-2024exp date	$18.5K	1
Atorvastatin calcium tablets 40 MG, 90sct batch no. 4kx035 mfg. date apr-2024exp date	$14.0K	1
Atorvastatin calcium tablets 40 MG, 90sct batch no. 4kx037 mfg. date apr-2024exp date	$13.9K	1
Formoterol fumarate inhalation solution,20mcg/2ML 30x2ml ( qty.256 packs) net conent of 0.16 GM of bulk drug)	$405	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Omega	Nutritional Supplements	$1.3M	33	6.8%	4
2	Vati	Ayurvedic & Herbal Products	$200.0K	4	0.8%	18

Lifestar Pharma Llc C/O imports 2 pharmaceutical products across 2 categories into United States totaling $1.5M.

Lifestar Pharma Llc C/O — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Lifestar Pharma LLC, a subsidiary of Mankind Pharma Limited, is a pharmaceutical company headquartered in Mahwah, New Jersey. Established in 2016, Lifestar Pharma focuses on developing and marketing affordable, high-quality specialty generics for the U.S. market. The company leverages its parent company's expertise to build a strategic portfolio of complex generics, including ophthalmic solutions, oral solids, inhalation solutions, and injectables.

As a pharmaceutical importer and buyer, Lifestar Pharma plays a significant role in the U.S. pharmaceutical distribution network. By sourcing finished pharmaceutical formulations from India, the company ensures a steady supply of diverse and specialized products to meet the needs of the U.S. healthcare sector. This strategic sourcing approach allows Lifestar Pharma to offer a range of generics that complement existing market offerings, thereby enhancing competition and accessibility.

2Distribution Network

Lifestar Pharma's distribution network is centered around its New Jersey headquarters, which serves as the primary hub for operations. The company collaborates with logistics partners to manage the importation and distribution of pharmaceutical products across the United States. While specific warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic partnerships and centralized operations suggest a well-coordinated supply chain designed to efficiently deliver products nationwide.

3Industry Role

In the U.S. pharmaceutical supply chain, Lifestar Pharma functions as a pharmaceutical importer and buyer. By sourcing finished pharmaceutical formulations from India, the company acts as an intermediary between Indian manufacturers and the U.S. market. This role involves ensuring that imported products meet U.S. regulatory standards and are effectively integrated into the domestic distribution network. Lifestar Pharma's activities contribute to the diversification and availability of generic pharmaceuticals in the U.S., supporting both healthcare providers and patients.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Lifestar Pharma Llc C/O

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Lifestar Pharma's sourcing strategy exhibits a high degree of concentration, with a total import value of $1.5 million USD from India across 37 shipments, all sourced from Mankind Pharma Limited. This single-source dependency indicates a strategic choice to maintain a consistent supply of specialized products from a trusted supplier. The stability of this relationship is evidenced by the consistent volume of imports and the absence of significant fluctuations in shipment data. However, such concentration also poses potential risks, including supply chain disruptions due to unforeseen events affecting the sole supplier.

2Supply Chain Resilience

Lifestar Pharma's supply chain resilience is closely tied to its exclusive partnership with Mankind Pharma Limited. The lack of publicly available information on backup suppliers and formulation diversity suggests a reliance on this singular source for product procurement. This reliance may expose the company to risks associated with supply chain disruptions, such as production delays or regulatory challenges faced by the supplier. Additionally, the absence of detailed information on shipping routes and regulatory compliance of key suppliers further underscores the need for a more diversified and resilient supply chain strategy.

Strategic Implications

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and marketing of pharmaceutical products. The Federal Food, Drug, and Cosmetic Act (FD&C Act) provides the legal framework governing these activities, ensuring that imported drugs meet standards for quality, safety, and effectiveness. For Indian pharmaceutical products, the FDA requires compliance with specific regulations, including the submission of New Drug Applications (NDAs) or Abbreviated New Drug Applications (ANDAs) for generics, as well as adherence to Good Manufacturing Practice (GMP) standards.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the U.S. include the submission of appropriate Affirmation of Compliance (A of C) codes, such as Drug Registration Number (REG), Drug Listing Number (DLS), and Drug Application Number (DA). These codes facilitate FDA review and ensure compliance with regulatory standards. Additionally, imported drugs must be manufactured in facilities that comply with FDA-recognized GMP standards, which may include EU GMP, WHO GMP, or PIC/S certifications. Wholesale distribution authorization is also required for entities involved in the distribution of pharmaceutical products within the U.S. market.

Lifestar Pharma Llc C/O — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Lifestar Pharma's focus on nutritional supplements and Ayurvedic & herbal products aligns with growing consumer demand for alternative and complementary health solutions in the U.S. market. The company's importation of these products suggests a strategic response to market trends favoring natural and holistic health approaches. By sourcing these products from India, Lifestar Pharma leverages the country's rich heritage in herbal medicine and its established reputation in the global pharmaceutical industry.

2Sourcing Profile

Lifestar Pharma's sourcing strategy emphasizes the procurement of finished pharmaceutical formulations, particularly in the categories of nutritional supplements and Ayurvedic & herbal products. This approach allows the company to offer a diverse range of products without the complexities associated with raw material sourcing or manufacturing. India's well-established pharmaceutical industry, with its adherence to international GMP standards, makes it a reliable source for these products.

3Market Positioning

By importing specialized pharmaceutical products, Lifestar Pharma serves a niche segment of the U.S. market that includes retail pharmacies, health and wellness stores, and consumers seeking alternative health solutions. The company's offerings cater to individuals interested in nutritional supplements and Ayurvedic & herbal products, positioning Lifestar Pharma as a key player in the alternative medicine sector within the broader pharmaceutical distribution network.

Seller's Guide — How to Become a Supplier to Lifestar Pharma Llc C/O

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Lifestar Pharma, particularly in the areas of nutritional supplements and Ayurvedic & herbal products. The company's current sourcing strategy, which relies on a single supplier, presents potential gaps that new suppliers can fill by offering complementary products or formulations. Establishing partnerships with Lifestar Pharma could lead to increased market penetration and diversification of the company's product portfolio.

2Requirements & Qualifications

Indian exporters seeking to supply products to Lifestar Pharma must ensure compliance with FDA regulations, including obtaining necessary import licenses and certifications. Manufacturing facilities should adhere to recognized GMP standards, such as EU GMP, WHO GMP, or PIC/S certifications. Additionally, products must meet FDA labeling requirements, including the use of English language and the inclusion of all mandated information. Serialization may also be required to enhance product traceability.

3How to Approach

Frequently Asked Questions — Lifestar Pharma Llc C/O

What products does Lifestar Pharma Llc C/O import from India?

Lifestar Pharma Llc C/O imports 2 pharmaceutical products across 2 categories. Top imports: Omega ($1.3M), Vati ($200.0K).

Who supplies pharmaceuticals to Lifestar Pharma Llc C/O from India?

Lifestar Pharma Llc C/O sources from 1 verified Indian suppliers. The primary supplier is Mankind Pharma Limited (100.0% of imports, $367.7K).

What is Lifestar Pharma Llc C/O's total pharmaceutical import value?

Lifestar Pharma Llc C/O's total pharmaceutical import value from India is $1.5M, based on 37 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Lifestar Pharma Llc C/O focus on?

Lifestar Pharma Llc C/O imports across 2 categories. The largest: Nutritional Supplements (86.5%), Ayurvedic & Herbal Products (13.5%).

Get Full Lifestar Pharma Llc C/O Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.